Claims for Patent: 8,030,472

Summary for Patent: 8,030,472

Title:	Compositions and methods for the modification of gene expression
Abstract:	Novel isolated plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.
Inventor(s):	Perera; Ranjan (Carlsbad, CA), Rice; Stephen (Auckland, NZ), Eagleton; Clare (Auckland, NZ), Wood; Marion (Auckland, NZ), Visser; Elizabeth (Auckland, NZ)
Assignee:	Arborgen, LLC (Summerville, SC) Rubicon Forests Holdings Limited (Auckland, NZ)
Application Number:	12/422,730
Patent Claims:	1. An isolated polynucleotide comprising at least SEQ ID NO: 132 having promoter activity. 2. A genetic construct comprising a polynucleotide of claim 1. 3. A genetic construct comprising, in the 5'-3' direction: (a) a promoter sequence, (b) a DNA sequence of interest; and (c) a gene termination sequence, wherein the promoter sequence comprises an isolated polynucleotide of claim 1. 4. The genetic construct of claim 3, further comprising a superubiquitin intron. 5. The genetic construct of claim 4, wherein said superubiquitin intron comprises residues 1196-2034 of SEQ ID NO: 142 or 143. 6. A transgenic plant cell comprising a genetic construct of claim 3. 7. A plant comprising a transgenic plant cell of claim 6, or a part or propagule or progeny thereof. 8. A method for modifying a target plant comprising stably incorporating into the genome of the plant a genetic construct of claim 3. 9. A method for producing a plant having modified gene expression comprising: (a) transforming a plant cell with a genetic construct of claim 3 to provide a transgenic cell; and (b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth. 10. A method for modifying a phenotype of a target plant, comprising stably incorporating into the genome of the target plant a genetic construct of claim 3. 11. An isolated polynucleotide comprising at least one sequence selected from the group consisting of SEQ ID NO: 132-135 and SEQ ID NO: 137-142 having promoter activity. 12. A genetic construct comprising a polynucleotide of claim 11. 13. A genetic construct comprising, in the 5'-3' direction: (a) a promoter sequence, (b) a DNA sequence of interest; and (c) a gene termination sequence, wherein the promoter sequence comprises an isolated polynucleotide of claim 11. 14. A transgenic plant cell comprising a genetic construct of claim 13. 15. A plant comprising a transgenic plant cell of claim 14, or a part or propagule or progeny thereof. 16. A method for modifying a target plant comprising stably incorporating into the genome of the plant a genetic construct of claim 13. 17. A method for producing a plant having modified gene expression comprising: (a) transforming a plant cell with a genetic construct of claim 13 to provide a transgenic cell; and (b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth. 18. A method for modifying a phenotype of a target plant, comprising stably incorporating into the genome of the target plant a genetic construct of claim 13.

Details for Patent 8,030,472

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-02-24
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-02-24
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-02-24